CellStrat vs Imbue: Revenue, Funding & Team Size Compared
CellStrat generates $6.4M in revenue; Imbue generates $11.5M. Imbue is 1.8× bigger than CellStrat by revenue. The table below compares CellStrat and Imbue on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  CellStratThis company |  Imbue |
|---|---|---|
| Revenue | $6.4M | $11.5M |
| Valuation | $96M | $1B |
| Funding raised | $140K | $212M |
| Team size | 40 | 81 |
| Growth | Not disclosed | 34.5% |
| Founded | 2018 | 2021 |
| HQ | Wilmington, United States | San Francisco, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
CellStrat at a glance
CellStrat generates $6.4M in revenue with 40 employees, headquartered in Wilmington, United States.
- Revenue
- $6.4M
- Valuation
- $96M
- Funding
- $140K
- Team size
- 40
- Founded
- 2018
CellStrat is an online platform intended to let software developers learn, develop and launch AI.
Imbue at a glance
Imbue generates $11.5M in revenue with 81 employees, headquartered in San Francisco, United States.
- Revenue
- $11.5M
- Valuation
- $1B
- Funding
- $212M
- Team size
- 81
- Founded
- 2021
Other CellStrat alternatives
CellStrat competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
CellStrat vs Imbue: frequently asked questions
Is CellStrat or Imbue bigger?
Imbue is the bigger company by revenue, at $11.5M against $6.4M for CellStrat.
How much revenue does CellStrat make?
CellStrat generates $6.4M in annual revenue with a team of 40.
How much revenue does Imbue make?
Imbue generates $11.5M in annual revenue with a team of 81.
How much funding has CellStrat raised?
CellStrat has raised $140K in total funding since it was founded in 2018.
How much funding has Imbue raised?
Imbue has raised $212M in total funding since it was founded in 2021.